rs113121239

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002253.4(KDR):​c.1116G>C​(p.Glu372Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,613,908 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0073 ( 16 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 14 hom. )

Consequence

KDR
NM_002253.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.0870

Publications

11 publications found
Variant links:
Genes affected
KDR (HGNC:6307): (kinase insert domain receptor) Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]
KDR Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008658975).
BP6
Variant 4-55110542-C-G is Benign according to our data. Variant chr4-55110542-C-G is described in ClinVar as Benign. ClinVar VariationId is 134619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00735 (1118/152152) while in subpopulation AFR AF = 0.0258 (1073/41512). AF 95% confidence interval is 0.0246. There are 16 homozygotes in GnomAd4. There are 547 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1118 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDRNM_002253.4 linkc.1116G>C p.Glu372Asp missense_variant Exon 9 of 30 ENST00000263923.5 NP_002244.1 P35968-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDRENST00000263923.5 linkc.1116G>C p.Glu372Asp missense_variant Exon 9 of 30 1 NM_002253.4 ENSP00000263923.4 P35968-1
KDRENST00000512566.1 linkn.1116G>C non_coding_transcript_exon_variant Exon 9 of 13 1
KDRENST00000647068.1 linkn.1129G>C non_coding_transcript_exon_variant Exon 9 of 30

Frequencies

GnomAD3 genomes
AF:
0.00732
AC:
1113
AN:
152034
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0258
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00184
AC:
463
AN:
251298
AF XY:
0.00139
show subpopulations
Gnomad AFR exome
AF:
0.0245
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000704
AC:
1029
AN:
1461756
Hom.:
14
Cov.:
33
AF XY:
0.000586
AC XY:
426
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0247
AC:
826
AN:
33468
American (AMR)
AF:
0.00159
AC:
71
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111936
Other (OTH)
AF:
0.00151
AC:
91
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00735
AC:
1118
AN:
152152
Hom.:
16
Cov.:
32
AF XY:
0.00735
AC XY:
547
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0258
AC:
1073
AN:
41512
American (AMR)
AF:
0.00203
AC:
31
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
67988
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000335
Hom.:
1
Bravo
AF:
0.00797
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0191
AC:
84
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00244
AC:
296
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Capillary infantile hemangioma Benign:1
Jul 30, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.11
T;T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.59
.;T
MetaRNN
Benign
0.0087
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.46
N;N
PhyloP100
0.087
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.56
.;N
REVEL
Benign
0.12
Sift
Benign
0.32
.;T
Sift4G
Benign
0.44
.;T
Polyphen
0.51
P;P
Vest4
0.14
MutPred
0.36
Loss of disorder (P = 0.2161);Loss of disorder (P = 0.2161);
MVP
0.18
MPC
0.22
ClinPred
0.016
T
GERP RS
1.5
Varity_R
0.25
gMVP
0.56
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113121239; hg19: chr4-55976709; API